385 Oyster Point Blvd., Suite 5/6 South San Francisco, CA 94080 info@acterisinc.com +1 888 774 7472

News

Acteris Announces Publication of Novel Cancer Immunotherapy Discoveries in the Journal Nature

Acteris Inc., (Acteris), a biotechnology company focused on developing innovative immunotherapies and immunodiagnostics to treat cancer, today announced the publication of research findings in Nature elucidating cancer mechanisms of action that correlate with patient responses to a new class of PD1/PDL1 blocking therapies for melanoma. Specifically, the team validated a signature that predicted response to...
Read more